PHARMACIE PLASKY: what changed
What changed
PHARMACIE PLASKY
NACE 47.730, Retail sale of pharmaceutical products
filed annual accounts (NBB)
Net result for the year
-€7,027
2024 · €79,781-€86,808
Equity
€666,089
2024 · €713,116-€47,027
Cash
€65,129
2024 · €37,119+€28,010
Balance sheet total
€1.5m
2024 · €1.7m-€138,929
Largest movements
Assets
- Receivables within one year -€109,974
down €109,974 (-11.2%), from €986,077 to €876,103
of which Other amounts receivable: -€63,242
- Tangible fixed assets -€54,024
down €54,024 (-10.6%), from €508,825 to €454,801
of which Other tangible fixed assets: -€32,682
- Cash +€28,010
up €28,010 (+75.5%), from €37,119 to €65,129
mainly Receivables within one year (+€109,974) and Depreciation (+€57,105)
Equity and liabilities
- Trade debts -€69,098
down €69,098 (-38.3%), from €180,237 to €111,139
- Profit (loss) carried forward -€47,027
down €47,027 (-59.4%), from €79,126 to €32,099
- Other debts -€23,621
down €23,621 (-8.2%), from €288,154 to €264,533
Income statement
- Gross operating margin -€63,533
down €63,533 (-23.6%), from €268,711 to €205,178
- Depreciation +€29,916
up €29,916 (+110%), from €27,189 to €57,105
- Taxes -€10,125
down €10,125, from €9,678 to -€447
- Staff costs +€4,030
up €4,030 (+3.1%), from €130,901 to €134,931
Change in the result, 2024 to 2025
For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.
Result 2024
€79,781
Gross operating margin
-€63,533
Staff costs
-€4,030
Depreciation
-€29,916
Other operating charges
+€41
Other operating items
+€2,406
Financial income
-€726
Financial charges
-€1,175
Taxes
+€10,125
Result 2025
-€7,027
raises the resultlowers the resultnot broken down further in the accounts
Derived cash bridge
The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.
From operations
+€73,563
Investment
-€2,741
Financing
-€42,813
Cash 2024
€37,119
From operations (derived)
+€73,563
Net result for the year
-€7,027
Depreciation
+€57,105
Stocks and contracts
+€5,102
Receivables within one year
+€109,974
Deferred charges and accrued income
-€2,501
Provisions
-€4,740
Trade debts
-€69,098
Tax, wage and social debts
+€8,370
Other debts
-€23,621
Investment (derived)
-€2,741
Investment in fixed assets (net)
-€2,741
Financing
-€42,813
Debts after one year
-€2,253
Short-term financial debts
-€560
Contributions, distributions and other
-€40,000
Cash 2025
€65,129
brings cash intakes cash out
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €1,652,709 | €1,513,780 | -€138,929 | -8.4% |
| Fixed assets | 21/28 | €516,765 | €462,401 | -€54,364 | -10.5% |
| Tangible fixed assets | 22/27 | €508,825 | €454,801 | -€54,024 | -10.6% |
| Land and buildings | 22 | €3,635 | €3,264 | -€371 | -10.2% |
| Plant, machinery and equipment | 23 | €16,097 | €14,362 | -€1,735 | -10.8% |
| Furniture and vehicles | 24 | €178,033 | €158,798 | -€19,235 | -10.8% |
| Other tangible fixed assets | 26 | €311,060 | €278,378 | -€32,682 | -10.5% |
| Financial fixed assets | 28 | €7,940 | €7,600 | -€340 | -4.3% |
| Current assets | 29/58 | €1,135,944 | €1,051,380 | -€84,565 | -7.4% |
| Stocks and contracts in progress | 3 | €110,389 | €105,287 | -€5,102 | -4.6% |
| Stocks | 30/36 | €110,389 | €105,287 | -€5,102 | -4.6% |
| Amounts receivable within one year | 40/41 | €986,077 | €876,103 | -€109,974 | -11.2% |
| Trade receivables | 40 | €117,055 | €70,323 | -€46,732 | -39.9% |
| Other amounts receivable | 41 | €869,022 | €805,780 | -€63,242 | -7.3% |
| Cash at bank and in hand | 54/58 | €37,119 | €65,129 | +€28,010 | +75.5% |
| Deferred charges and accrued income | 490/1 | €2,359 | €4,860 | +€2,501 | +106% |
| Total equity and liabilities | 10/49 | €1,652,709 | €1,513,780 | -€138,929 | -8.4% |
| Equity | 10/15 | €713,116 | €666,089 | -€47,027 | -6.6% |
| Contributions | 10/11 | €18,592 | €18,592 | = | 0.0% |
| Reserves | 13 | €615,398 | €615,398 | = | 0.0% |
| Non-distributable reserves | 130/1 | €1,859 | €1,859 | = | 0.0% |
| Reserves not available under the articles | 1311 | €1,859 | €1,859 | = | 0.0% |
| Tax-exempt reserves | 132 | €8,019 | €8,019 | = | 0.0% |
| Distributable reserves | 133 | €605,519 | €605,519 | = | 0.0% |
| Profit (loss) carried forward | 14 | €79,126 | €32,099 | -€47,027 | -59.4% |
| Provisions and deferred taxes | 16 | €4,740 | - | -€4,740 | |
| Provisions for liabilities and charges | 160/5 | €4,740 | - | -€4,740 | |
| Other liabilities and charges | 164/5 | €4,740 | - | -€4,740 | |
| Amounts payable | 17/49 | €934,853 | €847,692 | -€87,162 | -9.3% |
| Amounts payable after more than one year | 17 | €409,502 | €407,249 | -€2,253 | -0.6% |
| Financial debts | 170/4 | €409,502 | €407,249 | -€2,253 | -0.6% |
| Amounts payable within one year | 42/48 | €525,351 | €440,442 | -€84,909 | -16.2% |
| Financial debts | 43 | €45,938 | €45,378 | -€560 | -1.2% |
| Credit institutions | 430/8 | €45,938 | €45,378 | -€560 | -1.2% |
| Trade debts | 44 | €180,237 | €111,139 | -€69,098 | -38.3% |
| Suppliers | 440/4 | €180,237 | €111,139 | -€69,098 | -38.3% |
| Taxes, remuneration and social security | 45 | €11,022 | €19,392 | +€8,370 | +75.9% |
| Taxes | 450/3 | - | €1,952 | +€1,952 | |
| Remuneration and social security | 454/9 | €11,022 | €17,440 | +€6,418 | +58.2% |
| Other amounts payable | 47/48 | €288,154 | €264,533 | -€23,621 | -8.2% |
| Remuneration, social security and pensions | 62 | €130,901 | €134,931 | +€4,030 | +3.1% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €27,189 | €57,105 | +€29,916 | +110% |
| Other operating charges | 640/8 | €46 | €6 | -€41 | -87.5% |
| Non-recurring operating charges | 66A | €2,406 | - | -€2,406 | |
| Gross operating margin | 9900 | €268,711 | €205,178 | -€63,533 | -23.6% |
| Operating profit (loss) | 9901 | €108,169 | €13,136 | -€95,033 | -87.9% |
| Financial income | 75/76B | €744 | €18 | -€726 | -97.6% |
| Recurring financial income | 75 | €744 | €18 | -€726 | -97.6% |
| Financial charges | 65/66B | €19,454 | €20,629 | +€1,175 | +6.0% |
| Recurring financial charges | 65 | €19,454 | €20,629 | +€1,175 | +6.0% |
| Profit (loss) for the period before taxes | 9903 | €89,459 | -€7,474 | -€96,933 | |
| Income taxes | 67/77 | €9,678 | -€447 | -€10,125 | |
| Profit (loss) for the period | 9904 | €79,781 | -€7,027 | -€86,808 | |
| Profit (loss) for the period to be appropriated | 9905 | €79,781 | -€7,027 | -€86,808 |
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Compare this company with its sector.Sector benchmark
Calculation and sources
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. Prepared on 7 November 2026 via checked.be.